WHAT'S NEW
What's New
What's New | Events
Events

Recent FDA Activities: Important Warning Letters, Notices and Areas of Particular Scrutiny by the Agency

Tuesday, November 13, 2012

Life Sciences Speaker Series

November 13, 2012 | 8:00-9:30 a.m.
Philadelphia Country Club
1601 Spring Mill Road
Gladwyne, PA 19035

The Life Sciences Speaker Series focuses on legal issues for life sciences, health care, medical device and pharmaceutical companies. Please join us for the next session of our series, "Recent FDA Activities: Important Warning Letters, Notices and Areas of Particular Scrutiny by the Agency."

Pepper partner Allan A. Thoen will present a roundup of recent FDA compliance and enforcement actions. Increased enforcement activity by the FDA is affecting many life science companies. This session will cover notable warning letters, untitled letters, site inspections, and other FDA statements and actions on a range of topics, including advertising and promotion, post-marketing reporting, GMP compliance, and use of social media. It will identify key areas of recent FDA scrutiny, and address practical implications for life science companies and strategies for minimizing exposure.

CLE credit will be available. There is no fee to attend this seminar.

To register, visit http://www.regonline.com/Pepper_111312.

For more information please contact Kim MacAlister at macalisterk@pepperlaw.com or 215.981.4249.


Copyright © 2014 Pepper Hamilton LLP | Use of This Site Subject to These Terms & Conditions | PRIVACY POLICY | Contact Us: phinfo@pepperlaw.com or 866.737.7372 | Find Pepper Hamilton LLP on Facebook | Pepper Hamilton LLP on LinkedIn | Follow Pepper Hamilton LLP on Twitter | Pepper Hamilton LLP YouTube Channel | View Pepper Hamilton LLP's documents on JD Supra